A Study Exploring Olaparib and Temozolomide in Small Cell Lung Cancer

Anna Farago, MD, PhD, discusses a phase I study of olaparib (Lynparza) and temozolomide (Temodar) in patients with small cell lung cancer who had progression after 1 prior line of platinum-based chemotherapy.

Related Videos
Expert on NSCLC
Experts on NSCLC
Related Content